Barry Sherman, who died earlier this month under suspicious circumstances, had set the tone for generic drugmaker's aggressive litigation approach.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,